LAURUS LABS
Back to Balance Sheet
|
LAURUS LABS Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹3,540 Cr | ₹3,112 Cr | ₹2,432 Cr | ₹2,681 Cr | ₹2,457 Cr |
What is the latest Total Current Liabilities ratio of LAURUS LABS ?
Year | Total Current Liabilities |
---|---|
Mar2025 | ₹3,540 Cr |
Mar2024 | ₹3,112 Cr |
Mar2023 | ₹2,432 Cr |
Mar2022 | ₹2,681 Cr |
Mar2021 | ₹2,457 Cr |
How is Total Current Liabilities of LAURUS LABS Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹3,540 Cr | 13.73 | |
Mar2024 | ₹3,112 Cr | 27.96 | |
Mar2023 | ₹2,432 Cr | -9.28 | |
Mar2022 | ₹2,681 Cr | 9.11 | |
Mar2021 | ₹2,457 Cr | - |
Compare Total Current Liabilities of peers of LAURUS LABS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LAURUS LABS | ₹45,246.0 Cr | -4.4% | 7.4% | 99.8% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹383,570.0 Cr | -6.5% | -4.7% | -5.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,808.0 Cr | -7.1% | -11.5% | 32.7% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,734.0 Cr | -5.8% | 6.1% | 13.3% | Stock Analytics | |
CIPLA | ₹120,468.0 Cr | -4.3% | -0.1% | -1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹100,212.0 Cr | -5.8% | -6.8% | -11% | Stock Analytics |
LAURUS LABS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LAURUS LABS | -4.4% |
7.4% |
99.8% |
SENSEX | -0.7% |
-3.7% |
2.4% |
You may also like the below Video Courses